Reata Pharmaceuticals, Inc. Announces Second Quarter 2016 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AVGO
5. AAPL
6. ALNY
7. CNS
8. STLA
9. PTGX
10. EC

Go back to Reata Pharmaceuticals, Inc. Announces Second Quarter 2016 Financial and Operating Results

Reata Pharmaceuticals (RETA) Reports Q2 Loss of $0.05/Share

August 11, 2016 5:04 PM EDT

Reata Pharmaceuticals (NASDAQ: RETA) reported Q2 EPS of ($0.05), versus ($0.11) reported last year. Revenue for the quarter came in at $12.4 million, versus $12.4 million reported last year.

For earnings history and earnings-related data on Reata Pharmaceuticals (RETA) click here.

... More